ARTICLE | Distillery Therapeutics
Increasing hepatic TRIM31 expression for fatty liver
April 1, 2022 5:10 AM UTC
DISEASE CATEGORY: Hepatic
INDICATION: Non-alcoholic steatohepatitis (NASH); liver disease...
BCIQ Company Profiles
DISEASE CATEGORY: Hepatic
INDICATION: Non-alcoholic steatohepatitis (NASH); liver disease...
BCIQ Company Profiles
BCIQ Company Profiles